Stack Pharmaceuticals

Stack Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of high-value therapeutic products, primarily utilizing the FDA's 505(b)(2) regulatory pathway. The company targets niche markets with significant unmet medical needs, particularly in oncology supportive care and other specialized therapeutic areas. By leveraging existing clinical data for known molecules, Stack aims to reduce development risk and time-to-market for improved formulations. Their business model includes internal development as well as strategic partnerships for licensing and distribution. The company is led by a management team with a proven track record in drug delivery and regulatory strategy.